Chronic Pain Clinical Trial
— fMRI/FMEXOfficial title:
A Pilot fMRI Study of Fibromyalgia: Tai Chi Intervention
Verified date | February 2016 |
Source | Tufts Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This exploratory study proposal is the first pilot brain imaging study to determine if Tai Chi can modulate brain resting state functional connectivity (rsFC) and brain morphometry among fibromyalgia (FM) patients and healthy controls.
Status | Completed |
Enrollment | 55 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Age 21 years or older. - Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for FM: (1) a history of widespread musculoskeletal pain on the right and left sides of the body as well as above and below the waist for a minimum duration of 3 months, and (2) pain in 11 or more of 18 specific tender points with moderate or greater tenderness reported upon digital palpation.22 - Fulfills the ACR 2010 diagnostic criteria for FM: (WPI =7 AND SS =5) OR (WPI 3-6 AND SS =9) and does not have a disorder that would otherwise explain the pain23 - Willing to complete a 12-week, twice-a-week Tai Chi exercise program. - Willing to abstain from Aerobic Exercise or other new formalized exercise programs until completion of the study. - Willing to undergo MRI at baseline and follow-up. Exclusion Criteria: - Prior experience with Tai Chi or other similar types of Complementary and Alternative Medicine in the past 1 year such as Qi gong and yoga since these share some of the principles of Tai Chi. - Dementia, neurological disease, cancer, cardiovascular disease, pulmonary disease, metabolic disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the Tai Chi programs, as determined by the study physicians. - Any other diagnosed medical condition known to contribute to FM symptomatology, such as thyroid disease, inflammatory arthritis, systemic lupus erythematosis, rheumatoid arthritis, myositis, vasculitis or Sjogren's syndrome. - Inability to pass the Physical Activity Readiness Questionnaire (PAR-Q) - Inability to pass the Mini-Mental Status examination (with a score below 24)24 Enrollment in any other clinical trial within the last 30 days - Plan to permanently relocate from the region during the trial period - Presence of any contraindications to fMRI scanning. Including but not limited to: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy, weight >300 lbs - Non-English Speaking. |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Tufts Medical Center | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Tufts Medical Center | Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Brain Resting State Functional Connectivity as measured by fMRI | rostral anterior cingulate cortex (rACC), a key region in descending pain modulatory system (DPMS) | Modulation of impaired rsFC and brain structure at 12 weeks | No |
Secondary | Cortical Thickness as measured by fMRI | Baseline and 12-week | No | |
Secondary | Fibromyalgia Symptom Severity as measured by FIQR Questionnaire | FIQR | Baseline, weekly, and 12-week | No |
Secondary | Widespread Pain Index as measured by Clinical Diagnostic Criteria for Fibromyalgia Questionnaire | Clinical Diagnostic Criteria for Fibromyalgia | Baseline and 12-week | No |
Secondary | Depression as measured by BECK-II Questionnaire | BECK-II | Baseline and 12-week | No |
Secondary | Stress/Anxiety as measured by Hospital Anxiety and Depression Scale | Hospital Anxiety and Depression Scale | Baseline and 12-week | No |
Secondary | Sleep Quality as measured by PSQI Questionnaire | PSQI | baseline and 12-week | No |
Secondary | Quality of Life as measured by visual analog scale and SF-36 Questionnaire | VAS, SF-36 | baseline and 12-week | No |
Secondary | Mindfulness as measured by Five Facet Mindfulness Questionnaire | FFMQ | baseline and 12-week | No |
Secondary | Self-Efficacy as by Chronic Pain and Self Efficacy Questionnaire | Chronic Pain Self Efficacy | baseline and 12-week | No |
Secondary | Quantitative Sensory Testing as measured by an Algometer | Pain threshold | baseline and 12-week | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|